pharmacie et médicaments – Vente du Doliprane à un fonds américain

This written question concerns the sale of Doliprane, a widely used painkiller in France, to an American investment fund. It seeks clarification on the implications of this acquisition for the French pharmaceutical sector and public health. The question highlights potential impacts on drug availability, pricing, and the strategic autonomy of France in the pharmaceutical industry. It aims to understand the government's position and any measures being considered.